029-83533393
   info@TaiBSbio.com
 
组织芯片,组织微阵列
 
DGA802肝外胆管癌及肝内胆管癌组织组合芯片,附病理分级、TNM和临床分期,80例/80点
点 数80例 数80
行 数8列 数10
点直径(mm)1.5厚度(µm)5.0
组织阵列类型石蜡包埋种 属人类
QA/QCH&E and IHC confirmed
ApplicationsRoutine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page.
Notes1.Please keep the slides at 4 ℃ after receiving, and make experiment within 3 months will be better.

2.Bake the slides for 30 minutes at 60℃ before the experiment;

3.Please choose a gentle repair method to avoid tissue detachment.

产品名:DGA802
 
肝外胆管腺癌及肝内胆管细胞癌组织组合微阵列,包含48例胆管腺癌,27例肝内胆管细胞癌,5例肝内胆管组织,一例一点
 
 
询价  Tel: 029-83533393
 
下载说明书
 
 
Legend:
Liv
-Liver
Com
-Common bile duct
Bil
-Bile duct
 
Malignant (I)
 
Malignant (IA)
 
Malignant (IB)
 
Malignant (II)
 
Malignant (IIA)
 
Malignant (IIB)
 
Malignant (III)
 
Malignant (IVA)
 
Malignant (IVB)
 
NAT (*)
TISSUE  ARRAYS DGA802
1
2
3
4
5
6
7
8
9
10
A
BIL
BIL
BIL
BIL
BIL
BIL
BIL
COM
COM
COM
B
COM
COM
BIL
COM
BIL
COM
BIL
COM
COM
BIL
C
BIL
COM
BIL
BIL
COM
BIL
COM
COM
COM
COM
D
COM
COM
BIL
COM
COM
COM
COM
COM
COM
COM
E
COM
COM
COM
COM
BIL
BIL
BIL
COM
LIV
LIV
F
LIV
LIV
LIV
LIV
LIV
LIV
LIV
LIV
LIV
LIV
G
LIV
LIV
LIV
LIV
LIV
LIV
LIV
LIV
LIV
LIV
H
LIV
LIV
LIV
LIV
LIV
LIV
LIV
LIV
LIV
LIV
 
PosNoAgeSexOrgan_Anatomic_SitePathology_diagnosisGradeTNMStageTypeisBackUp
A1157MBile ductAdenocarcinoma1T3N0M0IIAMalignantN
A2253MBile ductAdenocarcinoma (sparse)1T2N0M0IBMalignantN
A3362MBile ductAdenocarcinoma1T2N0M0IBMalignantN
A4442FBile ductAdenocarcinoma (sparse)2T2N0M0IBMalignantN
A5578MBile ductAdenocarcinoma1T1N0M0IAMalignantN
A6659FBile ductAdenocarcinoma1T3N1M0IIBMalignantN
A7753MBile ductAdenocarcinoma2T3N0M0IIAMalignantN
A8870FCommon bile ductPapillary adenocarcinoma1T1N0M0IAMalignantN
A9951FCommon bile ductAdenocarcinoma (sparse)1T3N0M0IIAMalignantN
A101067MCommon bile ductAdenocarcinoma1T3N0M0IIAMalignantN
B11152FCommon bile ductAdenocarcinoma1T2N0M0IBMalignantN
B21258MCommon bile ductAdenocarcinoma2T3N0M0IIAMalignantN
B31364FBile ductAdenocarcinoma2T3N0M0IIAMalignantN
B41468MCommon bile ductAdenocarcinoma2T2N0M0IBMalignantN
B51562MBile ductAdenocarcinoma with degeneration2T3N1M0IIBMalignantN
B61665MCommon bile ductAdenocarcinoma2T2N0M0IBMalignantN
B71760MBile ductAdenocarcinoma2T2N0M0IBMalignantN
B81869MCommon bile ductAdenocarcinoma (sparse)*T3N1M0IIBMalignantN
B91974FCommon bile ductAdenocarcinoma2T2N0M0IBMalignantN
B102071MBile ductAdenocarcinoma3T2N0M0IBMalignantN
C12162MBile ductAdenocarcinoma2T3N0M0IIAMalignantN
C22266FCommon bile ductAdenocarcinoma (sparse)3T3N0M0IIAMalignantN
C32378FBile ductAdenocarcinoma (cataplasis)*T3N1M0IIBMalignantN
C42453FBile ductAdenocarcinoma (fibrous tissue and blood vessel)*T1N0M0IAMalignantN
C52528FCommon bile ductAdenocarcinoma1T2N0M0IBMalignantN
C62629MBile ductAdenocarcinoma (cataplasis)*T1N1M0IIBMalignantN
C72770FCommon bile ductAdenocarcinoma2T2N0M0IBMalignantN
C82865FCommon bile ductAdenocarcinoma2T3N0M0IIAMalignantN
C92953MCommon bile ductAdenocarcinoma2T3N0M0IIAMalignantN
C103058FCommon bile ductAdenocarcinoma3T3N1M0IIBMalignantN
D13165FCommon bile ductAdenocarcinoma2T2N0M0IBMalignantN
D23270FCommon bile ductAdenocarcinoma2T3N1M0IIBMalignantN
D33362FBile ductAdenocarcinoma2T2N0M0IBMalignantN
D43460MCommon bile ductPapillary adenocarcinoma2T2N1M0IIBMalignantN
D53552MCommon bile ductPapillary adenocarcinoma2T3N1M0IIBMalignantN
D63647MCommon bile ductAdenocarcinoma2T2N1M0IIBMalignantN
D73770FCommon bile ductAdenocarcinoma with necrosis3T3N0M0IIAMalignantN
D83853FCommon bile ductAdenocarcinoma3T3N0M0IIAMalignantN
D93950MCommon bile ductAdenocarcinoma3T2N0M0IBMalignantN
D104049MCommon bile ductAdenocarcinoma3T2N0M0IBMalignantN
E14175FCommon bile ductAdenocarcinoma3T2N0M0IBMalignantN
E24250MCommon bile ductAdenocarcinoma3T2N0M0IBMalignantN
E34373FCommon bile ductAdenocarcinoma3T3N1M0IIBMalignantN
E44441MCommon bile ductAdenocarcinoma3T2N1M0IIBMalignantN
E54572MBile ductAdenocarcinoma3T3N0M0IIAMalignantN
E64660FBile ductAdenocarcinoma3T2N1M0IIBMalignantN
E74769FBile ductAdenocarcinoma invades pancreas3T3N1M0IIBMalignantN
E84874MCommon bile ductAdenocarcinoma3T2N0M0IBMalignantN
E94936FLiverIntrahepatic cholangiocarcinoma2T2N0M0IIMalignantN
E105066MLiverIntrahepatic cholangiocarcinoma2T2N0M0IIMalignantN
F15152MLiverIntrahepatic cholangiocarcinoma with necriosis and degeneration2T3N1M0IVAMalignantN
F25251FLiverIntrahepatic cholangiocarcinoma2T3N0M0IIIMalignantN
F35345MLiverIntrahepatic cholangiocarcinoma3T3N0M0IIIMalignantN
F45464MLiverIntrahepatic cholangiocarcinoma3T4N0M0IVAMalignantN
F55565FLiverIntrahepatic cholangiocarcinoma2T2N1M0IVAMalignantN
F65634MLiverIntrahepatic cholangiocarcinoma with necrosis (sparse)2T2N0M0IIMalignantN
F75752MLiverIntrahepatic cholangiocarcinoma3T2N0M0IIMalignantN
F85866FLiverIntrahepatic cholangiocarcinoma2T1N0M0IMalignantN
F95958FLiverIntrahepatic cholangiocarcinoma2T2N0M0IIMalignantN
F106076MLiverIntrahepatic cholangiocarcinoma2T3N0M0IIIMalignantN
G16149MLiverIntrahepatic cholangiocarcinoma2T2N0M0IIMalignantN
G26262FLiverIntrahepatic cholangiocarcinoma2T2N0M0IIMalignantN
G36345MLiverIntrahepatic cholangiocarcinoma with necrosis2T2N0M0IIMalignantN
G46440FLiverIntrahepatic cholangiocarcinoma2T3N0M0IIIMalignantN
G56552FLiverIntrahepatic cholangiocarcinoma2T3N0M0IIIMalignantN
G66663MLiverIntrahepatic cholangiocarcinoma with necrosis2T3N0M0IIIMalignantN
G76769FLiverIntrahepatic cholangiocarcinoma with necrosis2T1N0M0IMalignantN
G86849MLiverIntrahepatic cholangiocarcinoma2T4N0M0IVAMalignantN
G96926MLiverIntrahepatic cholangiocarcinoma (sparse)2T3N0M0IIIMalignantN
G107046MLiverIntrahepatic cholangiocarcinoma2T2N0M0IIMalignantN
H17145FLiverIntrahepatic cholangiocarcinoma3T2N0M0IIMalignantN
H27265FLiverIntrahepatic cholangiocarcinoma3T4N0M1IVBMalignantN
H37348FLiverIntrahepatic cholangiocarcinoma3T2N0M0IIMalignantN
H47432MLiverIntrahepatic cholangiocarcinoma3T3N0M0IIIMalignantN
H57555FLiverIntrahepatic cholangiocarcinoma3T3N1M0IVAMalignantN
H67647MLiverAdjacent normal liver tissue and portal area***NATN
H77740MLiverAdjacent normal liver tissue and portal area***NATN
H87844FLiverAdjacent normal liver tissue and portal area***NATN
H97960MLiverAdjacent normal liver tissue and portal area***NATN
H108050MLiverAdjacent normal liver tissue and portal area***NATN
Tissue Marker
 
 
西安泰博斯生物科技有限公司

 
联系我们
地址:陕西西安市灞桥区长乐东路2999号
电话:029-83533393, 17792711553,
电子邮箱:taibsbio@163.com
QQ:3144647811
微信号:13002913390
邮政编码:710075
关于我们
西安泰博斯生物科技有限公司主要经营组织芯片的研发、销售,加工定制和与组织芯片有关的生物技术服务项目。公司目前拥有专业的病理医生和技术研发团队,并且具有庞大的组织标本库。样本库中组织微阵列种类多,病理类型齐全,同时根据客户需求情况进行制作加工新的组织微阵列,尽量满足每一个客户的需求。公司一直秉承着“认真、严谨、负责”的工作态度,致力于为广大客户提供质量好的产品和优质的服务。

更多详情